290
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Psychiatric disorders, acne and systemic retinoids: comparison of risks

, , , , , , , & show all
Pages 989-995 | Received 27 Feb 2017, Accepted 16 Jun 2017, Published online: 12 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gemma Vona-Giralt, Carles Vilaplana-Carnerero, Dan Ouchi, Ainhoa Gomez-Lumbreras, Rosa Morros & Maria Giner-Soriano. (2023) Risk of psychiatric events in women treated with isotretinoin: a self-controlled study with SIDIAP database. Expert Opinion on Drug Safety 22:3, pages 213-219.
Read now

Articles from other publishers (13)

Teng-Li Lin, Ching-Min Kuo, Yi-Ling Chang, Hsiu J. Ho, Yi-Ju Chen & Chun-Ying Wu. (2023) Risk of Psychiatric Disorders in Patients with Psoriasis Prescribed Acitretin versus Disease-Modifying Antirheumatic Drugs: A Nationwide Matched Cohort Study. Dermatology 239:4, pages 635-645.
Crossref
Fredrik Upmark, Hugo Sjöqvist, Joseph F. Hayes, Christina Dalman & Håkan Karlsson. (2021) Doxycycline exposure during adolescence and future risk of non-affective psychosis and bipolar disorder: a total population cohort study. Translational Psychiatry 11:1.
Crossref
C. Droitcourt, F. Poizeau, S. Kerbrat, F. Balusson, E. Drezen, A. Happe, D. Travers, E. Oger & A. Dupuy. (2019) Isotretinoin and risk factors for suicide attempt: a population‐based comprehensive case series and nested case–control study using 2010–2014 French Health Insurance Data. Journal of the European Academy of Dermatology and Venereology 34:6, pages 1293-1301.
Crossref
J.-L. Schmutz. (2020) Alitrétinoïne (Toctino®) : données récentes de pharmacovigilance. Annales de Dermatologie et de Vénéréologie 147:4, pages 329-330.
Crossref
Victoria Quintas Fernandes, Martin K. Leme Silva & Ivana Cesarino. (2020) Determination of isotretinoin (13-cis-retinoic acid) using a sensor based on reduced graphene oxide modified with copper nanoparticles. Journal of Electroanalytical Chemistry 856, pages 113692.
Crossref
Sonja C. Molin & Thomas Ruzicka. 2020. Kanerva’s Occupational Dermatology. Kanerva’s Occupational Dermatology 1417 1431 .
Laura Vrignaud, Corinne Simon, Marie Sara Agier, Hélène Théophile, Valérie Gras-Champel, Frédérique Beau-Salinas, Céline Lengellé & Annie Pierre Jonville-Béra. (2019) Alitrétinoïne (Toctino®) : données françaises de pharmacovigilance. Therapies 74:5, pages 513-519.
Crossref
Bárbara R. Ferreira, José C. Cardoso, José P. Reis & Américo Figueiredo. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology 33 56 .
U. Blume-Peytavi, M. Bagot, D. Tennstedt, M. Saint Aroman, E. Stockfleth, A. Zlotogorski, V. Mengeaud, A.M. Schmitt, C. Paul, H.W. Lim, V. Georgescu, B. Dréno & T. Nocera. (2019) Dermatology today and tomorrow: from symptom control to targeted therapy. Journal of the European Academy of Dermatology and Venereology 33, pages 3-36.
Crossref
Alessandra Suuberg. (2019) Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris. Current Therapeutic Research 90, pages 27-31.
Crossref
Brittany Singleton, Shandrika Landry, Sunil Sirohi & Sara Al-Dahir. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 431 446 .
Sonja C. Molin & Thomas Ruzicka. 2018. Kanerva’s Occupational Dermatology. Kanerva’s Occupational Dermatology 1 16 .
Alessandra Suuberg. (2018) Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.